




- Generic medicines
- Biosimilar medicines
- Value added medicines
- Events
Access to generic and biosimilar medicines can be improved with coherent proposals for IP […]
Read moreThe European Parliament Own Initiative Report on an intellectual property […]
Read moreInnovation on existing, well-known molecules through repurposing can deliver huge benefits for patients and address unmet medical needs sustainably. Today […]
Read more